Velocity Fund Finals winner Vitameter is ready to break through the blood barrier
Vitameter co-founder James MacLean had multiple causes for celebration when I ran into him at the Bombshelter pub after the…
Vitameter co-founder James MacLean had multiple causes for celebration when I ran into him at the Bombshelter pub after the…
Last December, the MaRS Data Catalyst team published a study investigating the ethnic and gender diversity of Toronto startups.…
A conference dedicated to providing university students with opportunities in the healthcare industry takes over the University…
Canadian health care startups are receiving both attention and investment in 2015. The latest infusion goes to Toronto-based…
It takes a special kind of person to be in healthcare. Caring for others takes heart and an enormous amount of patience. At…
A first of its kind report has been released by Life Sciences Ontario (LSO) that shows the economic impact the sector is having…
In addition to the $25,000 EyeCheck took home last November at the University of Waterloo’s Velocity Fall Fund Finals…
MaRS Innovation is reporting that Sault Ste. Marie-based eQOL received $435,475 from the Ontario government last week in a…
Attendees at the Velocity Fall Fund Finals last November were shocked, shocked, when Suncayr didn’t walk home with one of…
It’s not easy being a wearable hardware startup. It’s also hard being an impact health tech startup. Now, a wearable health…
Tech in Motion, a new player to the Toronto events scene, is kicking off a series of events hosted in HIGHLINE VC with a drinks…
Last week, 10 startups from Toronto and Chicago pitched their wares as part of an event to help entrepreneurs from both cities…
The CVCA is reporting that Montreal-based CTI Life Sciences has held an initial close for its second fund, CTI II, with $134…
Toronto-based Interface Biologics announced this week that it has closed a Series B financing round led by DSM Venturing and…
The CVCA is reporting that Persistence Capital Partners (PCP) has placed a significant equity investment in continuing health…